News + PR

Most Recent

Meet at CPhI North America, Interphex Tokyo and CPhI World Wide in 2019.

12/13/2018

News Meet at CPhI North America, Interphex Tokyo and CPhI World Wide in 2019. coming soon News + PR Interested in Partnering with us? CONTACT US

Wes Wheeler joins Bushu Pharmaceuticals Holdings Limited as a Non-Executive Director

04/25/2017

News Wes Wheeler joins Bushu Pharmaceuticals Holdings Limited as a Non-Executive Director Saitama,Japan,April 25th,2017 – BushuPharmaceuticalsLimited(“Bushu”)announcesthatMr.Wes Wheeler will join the Board as a non-executive director of Bushu Pharmaceuticals Holdings Limited(“Bushu Holdings”). And he will be formally appointed in Shareholders’ meeting of Bushu Holdings which will be held in June 20th 2017. Mr. Wheeler is currently the CEO and Chairman of Marken a leading global pharmaceutical supply chain and logistics company. Prior to Marken, Mr. Wheeler was the CEO and President of Patheon Inc., a leading global CMO. Baring Private Equity Asia (“Baring”) has been the shareholder of Bushu since acquiring 100% of the company in December 2014. Supporting further growth and globalization expansion has been a strategic priority for Bushu and Barings. Commenting…

CMC Contract Manufacturing Outsourcing Expansion

02/28/2017

News CMC Contract Manufacturing Outsourcing Expansion We, Bushu Parmaceuticals (“Bushu”), has been engaged in the pharma contract manufacturing business with domestic and foreign pharmaceutical companies in Japan as the largest independent CMO in Japan. Each day we strive to meet the needs of our customers through the contract manufacturing of commercial drugs and to ensure the highest quality service at the same time. As background, over the past ten years, the need for contract manufacturing by pharmaceutical companies has increased, and we Bushu has benefited from this increase in demand. However, the trends in the CMO industry have started to change over the last few years due to the external environment, particularly the declining trend of the market for long-term listed drugs.…

Completion of Transfer of Business Operations of Eisai Misato Plant

04/01/2014

News Completion of Transfer of Business Operations of Eisai Misato Plant Bushu Pharmaceuticals, Ltd. (Head Office: Kawagoe-city, Saitama Prefecture, Japan; hereinafter “Bushu”) is pleased to announce that on March 31, 2014, it completed the transfer of business operations of Eisai Misato Plant (location: Saitama Prefecture, Japan), one of manufacturing facilities of Eisai Co., Ltd. (Head Office: Tokyo, Japan; hereinafter “Eisai”), which was announced in Bushu’s news release titled “Execution of Business Transfer Agreement with Eisai Co., Ltd. for the acquisition of business operations of Eisai Misato Plant” dated November 29, 2013. Misato Plant, a new manufacturing powerhouse of Bushu, commenced its operations today. With the acquisition of Misato Plant, Bushu has started a new fiscal year with a two-plant structure with its…

Interested in Partnering with us?